CIS 2027 Annual Meeting
  • Agenda
  • Abstracts
  • Attendee Information
    • Hotel Information
    • Parent & Family Resources
    • Registration Information
  • Exhibitors & Sponsors
    • Ancillary Meeting Requests
  • Contact Us
  • CIS Home Page
Quick Links
  • www.clinimmsoc.org

Connect with us

CIS 2027 Annual Meeting

  • Agenda
  • Abstracts
  • Attendee Information
    • Hotel Information
    • Parent & Family Resources
    • Registration Information
  • Exhibitors & Sponsors
    • Ancillary Meeting Requests
  • Contact Us
  • CIS Home Page
CIS 2027 Annual Meeting section header

Abstracts


ABSTRACT SUBMISSION GUIDELINES AND INFORMATION

 

 

SUBMISSION TYPES

CIS will accept both abstracts and case reports for the 2027 Annual Meeting. Submitters are required to to indicate which type of submission they have as part of the submission process. If submitting a case report, please indicate if it is a single case or is a case series as part of your abstract text. While addressing the specifics of the case(s) in the abstract, please try to state the broader impact of your work for the field of Clinical Immunology. 

GENERAL SUBMISSION GUIDELINES

  • All abstracts must be submitted online, via the CIS abstract submission portal.

  • You do not need to be a member of CIS to submit an abstract or case report.

  • Submissions must be no longer than 350 words.

  • CIS does not accept encore or previously presented abstracts as part of the Annual Meeting.

  • No patient photos may be submitted as part of the abstract or case report.

  • Only charts/figures are allowed to be included with submissions. Charts/figures must be uploaded in .doc or .docx format.

  • There is no requirement for formatting of the abstracts beyond what is listed above.

  • If accepted for presentation at the meeting, the abstract will be published as submitted into the 2027 Annual Meeting supplement. However, the Editors reserve the right to edit any abstract that contains grammatical errors.

AUTHOR LISTING

Authors should be listed in the order you would like them published in the Annual Meeting supplement. Each Submitter will be asked to indicate one person as the presenting author for the submission, who will present if the abstract is selected for a poster or oral abstract presentation.

ABSTRACT SUBMISSION TOPICS

Topics of interest for the 2027 Annual Meeting cover a wide range of topics. The list below, while not exhaustive, covers topics that attendees in the past have indicated a particular interest in.

  • B Cell Biology
  • Hematopoietic Cell Transplantation and Gene Therapy
  • Immune Dysregulation in IEI
  • Immune Modulating Therapies
  • Immunoglobulin Replacement Therapy
  • Infections in IEIs
  • Innate Immunity
  • NK Cell Biology
  • Novel Genetic Etiologies of IEIs
  • Psychosocial and Outcomes Research in IEI
  • IEI Registries
  • IEI and Aging (includes Adult-onset IEIs)
  • IEI and Cancer
  • IEI and Metabolism
  • T Cell Biology
  • Secondary Immunodeficiency
  • Systems Biology and “Omics” of IEI
  • EBV and IEIs
  • Gene and Variant curation and HPO terms for IEIs
  • Cytokines and Biomarkers in Immune Disorders
  • Phenocopies of IEIs
  • Bone Marrow Failure Syndromes
  • Mucosal immunity
  • Thymic function and Thymus implantation
  • Organ involvement in IEIs
  • Bronchiectasis in IEIs
  • Syndromic IEIs
  • IBD and IEIs
  • Atopy and IEIs
  • Diagnostic Immunology
  • Other Topics Related to Immune Deficiency and/or Dysregulation 

ABSTRACT EDITING

If the presenting author is no longer able to present the accepted abstract, please complete this form. Requests for change of presenting author must be received no later than February 12, 2027.

ABSTRACT WITHDRAWAL

If you would like to request a withdrawal of your abstract from the program, including printing in the journal supplement, please complete the form below. Requests for withdrawal must be received no later than FEB 12th, 2027.

Withdrawal Request

CHANGE OF PRESENTING AUTHOR

If the presenting author is no longer able to present the accepted abstract, please complete this form. Requests for change of presenting author must be received no later than February 12, 2027.

Change Presenting Author

 

Embargo Policy

Abstract titles and author lists are embargoed until a date and time determined by CIS. Abstract content is embargoed until the abstract supplement publication date and time. The embargo date for the 2027 Annual Meeting is Wednesday, April 7, 2027 at 8:00 a.m. CT. Any updated and/or new data that will be presented in a poster presentation or an oral presentation is embargoed until the time and date of the presentation.

 

Embargo requests outside of the set policies and any planned press releases and media alerts must be reviewed and approved in advance by CIS. Requests must be received in writing and should be sent to info@clinimmsoc.org

 

JHI

Authors of accepted abstracts have the option to have their abstracts published in the Journal of Human Immunology (JHI) in conjunction with the CIS Annual Meeting. Selected abstracts will be published in the journal and made available at the time of the meeting.

Important Dates

Pre-Registration

  • Early-Bird Registration:
    11/2/2026 – 1/9/2027
  • Regular Pre-Registration Rates:
    1/10/2027 – 3/14/2027
  • Pre-Registration Closes:
    3/15/2027

Abstracts

  • Submissions Open:
    9/30/2026
  • Last Day to Submit:
    12/7/2026
  • Applicants Notified:
    Week of 1/11/2027

Sponsors/Exhibitors

  • Sales Open: End of September
  • Sales Close: 3/12/27

CIS 2027

555 East Wells Street
Suite 1100
Milwaukee, WI 53202-3823 USA
Phone: (414) 224-8095
Fax: (414) 272-6070
Email: info@clinimmsoc.org

© 2026 Clinical Immunology Society. Legal Notices. Sunshine Act. Sitemap.